Exercise for Peripheral Neuropathy
(CIPN Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether exercise can more effectively treat chemotherapy-induced peripheral neuropathy (CIPN) than usual drug treatments. CIPN occurs when chemotherapy damages nerves, causing symptoms like tingling and numbness. Participants will either follow a home-based exercise program (the Exercise Intervention) or continue with usual care for six weeks. Individuals who have had cancer, received certain chemotherapy drugs in the last nine months, and experience significant CIPN symptoms may qualify for the trial. As an unphased trial, this study provides a unique opportunity to explore innovative treatment options beyond standard care.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It seems likely that you can continue your current medications, especially since the trial focuses on exercise as a treatment.
What prior data suggests that this exercise intervention is safe for treating chemotherapy-induced peripheral neuropathy?
Research has shown that exercise is generally safe for managing neuropathy symptoms. Some studies found that exercise can slow neuropathy progression by 20% in people with diabetes. This suggests exercise might also help with nerve problems caused by chemotherapy.
Exercise programs, including activities like walking and lifting weights, have improved symptoms and nerve function. This is encouraging because exercise is not only well-tolerated but also beneficial. Importantly, these studies did not report any serious side effects from exercise, making it a safer option compared to many medications.
Exercise is usually considered low-risk and is already recommended for many health conditions. Therefore, participating in a trial using exercise to help with neuropathy might be a safe choice.12345Why are researchers excited about this trial?
Researchers are excited about the exercise intervention for peripheral neuropathy because it offers a unique approach focusing on physical activity rather than medication. Unlike standard treatments, which often involve pain relievers or anti-seizure medications, this program involves a home-based, self-directed walking and resistance exercise regimen tailored to each participant. The goal is to improve nerve function and reduce symptoms through natural means, which could provide a non-invasive alternative with fewer side effects. Additionally, incorporating tactile sensitivity tests and optional MRIs allows for detailed monitoring of changes, potentially revealing new insights into how exercise impacts nerve health.
What evidence suggests that exercise might be an effective treatment for chemotherapy-induced peripheral neuropathy?
Research has shown that exercise can significantly alleviate symptoms of chemotherapy-induced peripheral neuropathy (CIPN). One study found that patients who exercised experienced less severe CIPN symptoms than those who did not. Another review found that exercise, particularly strength and aerobic training, effectively reduces symptoms and improves muscle and joint function in individuals with peripheral neuropathy. In this trial, participants in Arm 1 will undergo an exercise intervention, which includes a home-based, self-directed, individually tailored progressive walking and resistance program. Participants in Arm 2 will receive usual care. Additionally, exercise has been shown to increase pain tolerance, making it easier to manage pain associated with neuropathy. These findings suggest that exercise can be a beneficial treatment option for reducing CIPN symptoms.16789
Who Is on the Research Team?
Ian R Kleckner
Principal Investigator
University of Rochester NCORP Research Base
Are You a Good Fit for This Trial?
This trial is for adults with cancer who have nerve damage from chemotherapy, can understand English, and are expected to live at least six more months. They should be able to do some exercise and not have other health issues that make exercising unsafe. People who've had recent surgery or radiation (except hormone/biologic therapy) or already exercise regularly can't join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a 6-week home-based individually tailored progressive exercise intervention or standard care
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Exercise Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Rochester NCORP Research Base
Lead Sponsor
National Cancer Institute (NCI)
Collaborator